Health Coaching Added to Standard Therapy for Hypertension: Blood Pressure and Quality of Life
The Effect of Health Coaching on Hypertension Management on Blood Pressure and Quality of Life of Patients in Primary Health Care Facilities
1 other identifier
interventional
98
1 country
1
Brief Summary
The goal of this clinical trial is to learn if adding health coaching to standard therapy lowers blood pressure and increases quality of life in adults with hypertension receiving care at a primary care clinic. The main questions it aims to answer are: Does adding health coaching to standard therapy lower systolic blood pressure? Does adding health coaching to standard therapy lower diastolic blood pressure? Does adding health coaching to standard therapy increase quality of life? Researchers will compare standard therapy plus health coaching with standard therapy alone to see if adding health coaching results in greater reductions in blood pressure and greater improvements in quality of life. articipants will:
- Receive standard therapy for hypertension if assigned to the control group.
- Receive standard therapy plus four health coaching sessions over 3 months if assigned to the intervention group.
- Have their blood pressure measured before and after the study.
- Complete a quality-of-life questionnaire at the beginning and end of the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hypertension
Started Jul 2025
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 12, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 12, 2025
CompletedFirst Submitted
Initial submission to the registry
August 13, 2026
CompletedFirst Posted
Study publicly available on registry
August 18, 2026
CompletedAugust 21, 2026
August 1, 2026
4 months
August 13, 2026
August 19, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Change in Systolic Blood Pressure (SBP)
Change in systolic blood pressure from baseline to the end of the 3-month intervention period.
From baseline to 3 months
Change in Diastolic Blood Pressure (DBP)
Change in diastolic blood pressure from baseline to the end of the 3-month intervention period.
From baseline to 3 months
Change in Quality of Life Measured by WHOQOL-BREF
Change in quality of life from baseline to the end of the 3-month intervention period, assessed using the Indonesian version of the World Health Organization Quality of Life-BREF (WHOQOL-BREF) questionnaire consisting of 26 items. Scores are transformed to a 0-100 scale, with higher scores indicating better quality of life.
From baseline to 3 months
Study Arms (2)
Standard Therapy
ACTIVE COMPARATORParticipants in this arm will receive standard therapy for hypertension without health coaching.
Standard Therapy Plus Health Coaching
EXPERIMENTALParticipants in this arm will receive standard therapy for hypertension plus four health coaching sessions over 3 months.
Interventions
Four health coaching sessions delivered over 3 months in addition to standard therapy for hypertension.
Standard therapy for hypertension according to routine clinical care and the treating physician's clinical judgment.
Eligibility Criteria
You may qualify if:
- Patients with hypertension at the study site aged \>18 years.
- Patients diagnosed with hypertension within the previous 12 months.
- Current participants of the Prolanis program at the study site.
- Willing to participate in the study and provide written informed consent.
You may not qualify if:
- Patients with hypertension who are not registered as BPJS Kesehatan participants at the study FKTP.
- Patients with hypertension who are already controlled with standard treatment.
- Patients with hypertension with comorbidities (diabetes mellitus, stroke, or heart disease).
- Patients with hypertension who smoke.
- Patients with hypertension who have obesity.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Klinik Pratama Rawat Inap annisa dua
Citeureup, West Java, 16810, Indonesia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 13, 2026
First Posted
August 18, 2026
Study Start
July 28, 2025
Primary Completion
November 12, 2025
Study Completion
November 12, 2025
Last Updated
August 21, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share